Efficacy of once weekly teriparatide in patients with glucocorticoid-induced osteoporosis
Not Applicable
- Conditions
- Glucocorticoid-induced osteoporosis
- Registration Number
- JPRN-UMIN000011419
- Lead Sponsor
- Glucocorticoid-induced osteoporosis research group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 204
Inclusion Criteria
1) Patients who have been taking or are scheduled to take oral steroid at a dose equivalent to 5 mg/day of prednisolone or higher for at least 3 months
2) Patients aged 20 years or older
Exclusion Criteria
1) Patients who previously used bisphosphonate. However, use for up to 2 weeks, 6 months or more before the enrollment is allowed.
2) Patients who have used Teribone or Forteo in the past.
3) Patients for who have contraindications of teriparatide and alendronate.
4) Patients who have 3 or more lumbar vertebral bodies could not be evaluated in DXA.
5) Patients who have used denosumab within the 6 months before enrollment.
6) Patients who were considered as inappropriate for the study by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method